alexa Abstract | A REVIEW ON CAPTOPRIL ORAL SUSTAINED/CONTROLLED RELEASE FORMULATIONS

International Journal of Drug Development and Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Captopril provides effective treatment for hypertension and congestive heart failure. However clinical use requires the daily dose of 37.5-75mg to be taken at three times. Development of a prolonged action dosage form for captopril will bring many benefits. The development of oral controlled or sustained captopril formulations has been a challenge for a long period of time. The reason being the drug is highly water soluble, unstable in alkaline intestinal pH and decrease in bioavailability in presence of food. Various attempts have been made to regulate the release and increase the bioavailability of the drug. This review focuses the recent progress and attempts made on the oral sustained or controlled release formulation for captopril.

To read the full article Peer-reviewed Article PDF image

Author(s): CNITHYA SHANTHI RAKESH GUPTA ARUN KUMAR MAHATO

Keywords

Captopril, Controlled Release Formulations, Bioavailability

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords